Custom Health launches $8.5M public offering to fund acquisitions
What's the deal? Custom HealthDealroom has a profile for this one. Try Dealroom → Holdings has launched an overnight marketed public offering of units to raise up to US$8.8M. The Kelowna-based digital health company will sell units at US$3.63 each, with Stifel Nicolaus Canada Inc.Dealroom has a profile for this one. Try Dealroom → acting as sole agent and bookrunner.
The details: Each unit bundles one common share with a warrant to buy another share at US$4.33, exercisable for 60 months. A concurrent non-brokered private placement could add up to roughly US$7.33M on the same terms, potentially taking the total to about US$16.1M. The offering is set to close on or about November 13, 2026.
What's the money for? Proceeds will fund payments tied to previously announced acquisitions and associated costs, planned debt repayments, and working capital. It is as much a balance-sheet and integration measure as a growth raise.
Why now? The financing follows an acquisition-heavy year. Custom Health bought InnovativeRx in June, adding pharmacy operations, and completed its Spencer Health Solutions deal in September to bring smart medication-dispensing technology in-house.
What could go wrong? The raise is not yet closed and carries dilution risk, since each unit includes a share and a five-year warrant. Both the offering and the private placement remain subject to approvals, including from the Toronto Stock Exchange.
The signal: Custom Health, which helps patients manage medications and chronic conditions through in-home dispensing, remote monitoring, and pharmacist-led care, reported a 70% year-over-year jump in quarterly revenue in Q2. This raise shows the capital cost of knitting rapid acquisitions into a single platform.
Read more: stockhouse.com, Financial Times
Image credit: NavyMedicine
